Cardiorenal Syndrome: Diagnosis, Treatment, and Clinical Outcomes (Q37782283)

23 August 2017

title

Cardiorenal syndrome: diagnosis, treatment, and clinical outcomes (English)

1 reference

23 August 2017

Cardiorenal Syndrome: Diagnosis, Treatment, and Clinical Outcomes (English)

1 reference

https://api.crossref.org/works/10.1007/S11897-010-0025-5

22 June 2024

1 reference

2

W. H Wilson Tang

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20737257

22 June 2024

author name string

Kevin Shrestha

series ordinal

1

1 reference

23 August 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20737257

22 June 2024

publication date

1 December 2010

1 reference

full work available at URL

23 August 2017

http://www.current-reports.com/1546-9530/7/167

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20737257

http://link.springer.com/content/pdf/10.1007/s11897-010-0025-5.pdf

22 June 2024

file format

Portable Document Format

1 reference

https://api.crossref.org/works/10.1007/S11897-010-0025-5

http://link.springer.com/article/10.1007/s11897-010-0025-5/fulltext.html

22 June 2024

1 reference

https://api.crossref.org/works/10.1007/S11897-010-0025-5

http://link.springer.com/content/pdf/10.1007/s11897-010-0025-5

22 June 2024

1 reference

https://api.crossref.org/works/10.1007/S11897-010-0025-5

Current heart failure reports

22 June 2024

published in

1 reference

23 August 2017

volume

7

1 reference

23 August 2017

issue

4

1 reference

23 August 2017

page(s)

167-174

1 reference

The severe cardiorenal syndrome: 'Guyton revisited'.

23 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11897-010-0025-5

Cardio-renal syndromes: report from the consensus conference of the acute dialysis quality initiative

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-010-0025-5

Worsening renal function and prognosis in heart failure: systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-010-0025-5

Epidemiology of cardio-renal syndromes: workgroup statements from the 7th ADQI Consensus Conference

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-010-0025-5

Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-010-0025-5

Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-010-0025-5

Prevalence and significance of unrecognized renal insufficiency in patients with heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-010-0025-5

Creatinine kinetics and the definition of acute kidney injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-010-0025-5

Serum neutrophil gelatinase-associated lipocalin (NGAL) in predicting worsening renal function in acute decompensated heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-010-0025-5

Hormones and hemodynamics in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-010-0025-5

Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-010-0025-5

Acute cardio-renal syndrome: progression from congestive heart failure to congestive kidney failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-010-0025-5

Acute decompensated heart failure and the cardiorenal syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-010-0025-5

Aggravated renal dysfunction during intensive therapy for advanced chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-010-0025-5

Cardiorenal syndrome in decompensated heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-010-0025-5

Raised venous pressure: a direct cause of renal sodium retention in oedema?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-010-0025-5

Cardiorenal interactions: insights from the ESCAPE trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-010-0025-5

Potential effects of aggressive decongestion during the treatment of decompensated heart failure on renal function and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-010-0025-5

Decreased cardiac output, venous congestion and the association with renal impairment in patients with cardiac dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-010-0025-5

Increased central venous pressure is associated with impaired renal function and mortality in a broad spectrum of patients with cardiovascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-010-0025-5

Importance of venous congestion for worsening of renal function in advanced decompensated heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-010-0025-5

Venous congestion and endothelial cell activation in acute decompensated heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-010-0025-5

Intra-abdominal hypertension in the critically ill: it is time to pay attention.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-010-0025-5

Effects of increased renal parenchymal pressure on renal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-010-0025-5

Elevated intra-abdominal pressure in acute decompensated heart failure: a potential contributor to worsening renal function?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-010-0025-5

Prompt reduction in intra-abdominal pressure following large-volume mechanical fluid removal improves renal insufficiency in refractory decompensated heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-010-0025-5

Clinical trials of pharmacological therapies in acute heart failure syndromes: lessons learned and directions forward

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-010-0025-5

Managing acute renal failure in patients with acute decompensated heart failure: the cardiorenal syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-010-0025-5

Changes in brain natriuretic peptide levels and bioelectrical impedance measurements after treatment with high-dose furosemide and hypertonic saline solution versus high-dose furosemide alone in refractory congestive heart failure: a double-blind st

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-010-0025-5

Prednisone adding to usual care treatment for refractory decompensated congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-010-0025-5

Inflammation as a therapeutic target in heart failure? A scientific statement from the Translational Research Committee of the Heart Failure Association of the European Society of Cardiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-010-0025-5

Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-010-0025-5

Ultrafiltration is associated with fewer rehospitalizations than continuous diuretic infusion in patients with decompensated heart failure: results from UNLOAD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-010-0025-5

Sodium nitroprusside for advanced low-output heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-010-0025-5

Relaxin for the treatment of patients with acute heart failure (Pre-RELAX-AHF): a multicentre, randomised, placebo-controlled, parallel-group, dose-finding phase IIb study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-010-0025-5

Vasopressin and vasopressin antagonists in heart failure and hyponatremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-010-0025-5

Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-010-0025-5

Acute hemodynamic effects of tolvaptan, a vasopressin V2 receptor blocker, in patients with symptomatic heart failure and systolic dysfunction: an international, multicenter, randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-010-0025-5

Adenosine A1 antagonists and the cardiorenal syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-010-0025-5

The effects of KW-3902, an adenosine A1-receptor antagonist,on diuresis and renal function in patients with acute decompensated heart failure and renal impairment or diuretic resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-010-0025-5

The PROTECT pilot study: a randomized, placebo-controlled, dose-finding study of the adenosine A1 receptor antagonist rolofylline in patients with acute heart failure and renal impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-010-0025-5

Neutrophil gelatinase-associated lipocalin (NGAL) and progression of chronic kidney disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-010-0025-5

Serum and urinary biomarkers of acute kidney injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-010-0025-5

Transcriptional analysis of kidneys during repair from AKI reveals possible roles for NGAL and KIM-1 as biomarkers of AKI-to-CKD transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-010-0025-5

Tubular damage in chronic systolic heart failure is associated with reduced survival independent of glomerular filtration rate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-010-0025-5

The active role of venous congestion in the pathophysiology of acute decompensated heart failure

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20737257

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Kidney Injury Molecule-1 (KIM-1): a novel biomarker for human renal proximal tubule injury

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20737257

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

The influence of venous pressure on the isolated mammalian kidney

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20737257

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

1 reference

23 August 2017

1 reference